These findings offer a new perspective on the pathogenesis and pathophysiology of diarrheal disease and suggest that preventing mucin O-glycans from defects and maintaining symbiotic interaction between glycans and gut microbiota may be an alternative strategy for the treatment of diarrhea and intestinal diseases in children. The gene discussed is MUC5AC; the disease is diarrheal disease.